Category Archives: Recent Investment

SWAN Impact Network is pleased to announce participation in Yotta Energy’s recent $8M funding round led by Evergy Ventures and with participation from strategic investors BlueScope and Cricetus Felix Ventures and existing investors Copec WIND Ventures, EDP Ventures, Doral Tech Ventures.

Yotta Energy, a leading provider of innovative solar+storage solutions, will use the funding to help the company scale up manufacturing and accelerate the deployment of its SolarLEAF battery technology for commercial buildings.

More about the latest funding round can be found HERE.

SWAN participated in previous funding rounds with the company in 2019, 2020, and 2021.

SWAN Impact Network is pleased to announce a follow-on investment in Advanced Ionics’ recent Series A Round.

Advanced Ionics, which develops a new category of hydrogen electrolyzers useful for expanding green hydrogen production, recently closed a $12.5 million Series A funding round led by bp ventures, with additional investors including Clean Energy Ventures, Mitsubishi Heavy Industries, and GVP Climate.

The new funding round will help catalyze Advanced Ionics’ growth and facilitate the initial deployment of its Symbion water vapor electrolyzer technology for heavy industry. And water vapor electrolyzers address two of the biggest obstacles to expanding green hydrogen production: cost and electricity requirements.

More about the latest funding round can be found HERE.

SWAN participated in earlier funding rounds of the company in 2021.

SWAN is pleased to announce follow-on funding in Hubly Surgical, which recently raised $3 million in an oversubscribed Funding Round.

In May 2023, Hubly Surgical announced that HUBLY DRILL, the first and only single-use cranial drill with advanced features for safety and efficiency in any setting, is FDA-cleared and now available for sale. Read more HERE.

Following FDA Clearance, this investment comes primarily from the Hubly commission-only distributor sales force, pre-existing investors, and the neurosurgeons and physicians who share the company’s vision.

SWAN previously invested in Hubly in 2021.

The SWAN Impact Network is pleased to announce an investment in Nano PharmaSolutions.

Nano PharmaSolutions helps pharma companies to rapidly advance to the first-in-human clinical stage by making new drugs more soluble and human bio-available.